Dermata Therapeutics
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -2,967 | -1,926 | -1,900 | -1,691 |
Net Income | -2,967 | -1,847 | -1,861 | -1,691 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -2,532 | -2,479 | -1,329 | -1,803 |
Cash | 4,412 | 6,945 | 7,521 | 4,664 |
Basic Shares | 4,022 | 3,858 | 1,223 | 1,026 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -7,773 | -12,287 | 247 | -9,674 |
EBIT | -24,800 | -7,794 | -9,674 | |
Net Income | -7,558 | -12,287 | -7,795 | -9,610 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -7,757 | -11,162 | -6,408 | -8,834 |
Cash | 7,521 | 3,161 | 7,438 | 6,241 |
Basic Shares | 926 | 153 | 19 | 4 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.74 |
2026-03-31 | -$0.48 |
2025-12-31 | -$1.52 |
2025-09-30 | -$1.65 |